fialuridine April 12, 2017 fialuridine Trade Name Orphan Indication Adjunctive treatment of chronic active hepatitis B USA Market Approval USA USA Designation Date 1992-07-24 00:00:00 Sponsor Oclassen Pharmaceuticals, Inc.;100 Pelican Way;San Rafael, California, 94901
